Introduction {#sec1}
============

The subventricular zone (SVZ) of the lateral ventricle walls is one of the main germinal zones in the adult mammalian brain ([@bib1]). Adult neurogenesis within the SVZ proceeds via a well-defined sequence of events. Slowly dividing stem cells, so-called B cells, give rise to rapidly proliferating transient amplifying C-cells. Neuroblasts are generated from these proliferating progenitors and migrate to the olfactory bulb, where they differentiate into interneurons ([@bib29; @bib13]).

The environment provided by the cells in the SVZ is very different from that of the surrounding nonneurogenic regions. The unique proneurogenic conditions in the SVZ make up what is called the neurogenic niche ([@bib32; @bib39; @bib42]). A specialized vasculature with reduced pericyte coverage is an integral part of the SVZ neurogenic niche ([@bib42]). When stem cells in the SVZ transition from the quiescent B cell stage to the proliferative C-cell stage, they move from a position close to the ependymal cell layer to the underlying vasculature ([@bib22]). As the C-cells develop into migratory neuroblasts (A-cells), the vasculature in the SVZ and the rostral migratory stream (RMS) is used as a migratory scaffold, guiding the cells toward the olfactory bulbs ([@bib5]). These studies suggest an intimate relationship between SVZ stem and progenitor cells and the specialized vasculature; however, whether the stem and progenitor cells can directly influence the surrounding vasculature is less clear.

We and others have previously studied the effects of intracerebroventricular (ICV) epidermal growth factor (EGF) infusion on neural stem and progenitor cells in the SVZ. Apart from inducing proliferation, EGF infusion reduces the number of neuroblasts, induces atypical migration of oligodendrocyte-like progenitors, stimulates expansion and migration of OLIG2-expressing progenitors in the rostral migratory stream, and leads to polyp formation in the rat SVZ ([@bib9; @bib23; @bib14; @bib17; @bib27; @bib28]).

Microglia are the resident immune cells of the brain, derived from yolk-sac macrophages. Microglia precursors invade the brain during development before vascularization occurs ([@bib2]). In addition to functions in the immune response and tissue homeostasis, microglia modulate SVZ adult neurogenesis ([@bib45; @bib25]). In the retina, microglia are implicated in vascular development, angiogenesis, and capillary sprouting ([@bib8; @bib43; @bib4]).

We introduce a reproducible model of inducing angiogenesis in the adult SVZ by extended ICV infusion of EGF. Within 14 days of infusion, EGF-induced SVZ polyps attract blood vessels, a process that is preceded by microglia/macrophages accumulation and cell death. The current study suggests an important role of microglia/macrophages in the induction of brain angiogenesis and provides a model by which the early stages of angiogenesis can be readily explored.

Results {#sec2}
=======

Development of Epidermal-Growth-Factor-Induced Polyp Formation Results in Angiogenesis {#sec2.1}
--------------------------------------------------------------------------------------

We have previously described how ICV infusion of EGF increases proliferation and size of the rat subventricular zone. Prolonged infusion for 14 days induces the formation of focal dysplastic polyps ([@bib23; @bib27]). The EGF-induced polyps show distinct expression of neural stem cell and progenitor markers and display unique ultrastructural characteristics. In the current study, EGF or artificial cerebrospinal fluid (aCSF) was continuously infused ICV for 7 and 14 days to progressively study polyp formation. No polyps were found in any of the groups receiving aCSF only ([Figure 1](#fig1){ref-type="fig"}A). Polyp formation was present in all animals receiving EGF infusion. An average of 1.9 ± 0.5 polyps per 40 μm section (n = 4, mean ± SE) was found in the lateral ventricles following 14 days of EGF infusion. Studying polyps after 7 and 14 days of EGF infusion revealed distinct differences in polyp appearance. Overall, polyps formed over 14 days of EGF infusion were almost three times larger compared to polyps formed over 7 days (22,120 ± 9,366 μm^2^ and 63,702 ± 15,094 μm^2^, respectively, n = 4 for both groups, p = 0.0034, mean ± SE). A subset of polyps formed convex protrusions from the SVZ showing a relatively small polyp diameter (∼50 μm) ([Figure 1](#fig1){ref-type="fig"}B). Other polyps were of a spherical shape, occasionally only connected to the SVZ via a small "stem" ([Figure 1](#fig1){ref-type="fig"}C). Polyps formed after 14 days of EGF infusion were not only larger, but persistently contained blood vessels. Some polyps had a single vessel leading into the core of the polyp ([Figure 1](#fig1){ref-type="fig"}D), whereas others had extensive vascularization in the polyp core ([Figure 1](#fig1){ref-type="fig"}E). The polyp blood vessels were more heterogeneous with respect to vessel diameter and morphology than were blood vessels of the control SVZ ([Figure 1](#fig1){ref-type="fig"}E).

Changes in Microglia/Macrophages and Angiogenesis Mark Distinct Stages in Polyp Progression {#sec2.2}
-------------------------------------------------------------------------------------------

Because of the methodological difficulties in separating microglia from peripherally recruited macrophages, we will make no such distinction and use the term microglia/macrophage or refer to the antigen used to label said population of cells. We used an antibody against IBA1 to label microglia/macrophages and in smaller polyps, we observed IBA1^+^ cells scattered throughout the polyps at a density similar to the underlying SVZ ([Figure 2](#fig2){ref-type="fig"}A). In other polyps the distribution of IBA1^+^ cells was less random, with a tendency toward accumulating in the core ([Figure 2](#fig2){ref-type="fig"}B). The morphology of IBA1^+^ cells was of a more activated phenotype with shorter and thicker cellular processes compared to IBA1^+^ cells in smaller polyps ([Figure 2](#fig2){ref-type="fig"}B). In animals receiving 14 days of EGF infusion, we found polyps with significant accumulation of IBA1^+^ cells, occasionally with a single vessel leading into the polyp core ([Figure 2](#fig2){ref-type="fig"}C). The majority of IBA1^+^ cells in the polyp core had a spherical cell body indicative of amoeboid microglia/macrophages ([Figure 2](#fig2){ref-type="fig"}C). In highly vascularized polyps, IBA1^+^ cells were predominantly located in close association with blood vessels, displaying a more ramified appearance compared to amoeboid IBA1^+^ cells in nonvascularized polyps ([Figure 2](#fig2){ref-type="fig"}D). Combining polyp appearance, vascularization, and IBA1^+^ cell morphology, distinct stages in polyp development became apparent. To facilitate analysis of polyp growth and vascularization, we defined four stages in polyp development (I--IV). At stage I, polyps are beginning to protrude into the ventricular space ([Figure 1](#fig1){ref-type="fig"}B), containing IBA1^+^ cells with a ramified morphology ([Figure 2](#fig2){ref-type="fig"}A). At stage II, the polyps take on a spherical shape ([Figure 1](#fig1){ref-type="fig"}C) and certain compartmentalization of IBA1^+^ cells is present ([Figure 2](#fig2){ref-type="fig"}B). Early signs of IBA1^+^ cell core accumulation are present and the IBA1^+^ cell morphology is more activated, with a round shape and shorter processes ([Figure 2](#fig2){ref-type="fig"}B). Seven days of EGF infusion results only in polyps of stages I and II. Following seven additional days of EGF infusion, the first signs of angiogenesis ([Figure 1](#fig1){ref-type="fig"}D) and extensive IBA1^+^ cell core accumulation ([Figure 2](#fig2){ref-type="fig"}C) define stage III polyps. The final stage (IV) is characterized by dense polyp core vascularization ([Figure 1](#fig1){ref-type="fig"}E) and vessel-associated IBA1^+^ cells ([Figure 2](#fig2){ref-type="fig"}D).

Infusion of EGFR (EGF receptor) ligand TGFα (transforming growth factor alpha) has previously been reported to increase the number of microglia in the SVZ. The TGFα-induced microglia were almost exclusively bromodeoxyuridine (BrdU) negative, suggesting recruitment of microglia to the EGFR-stimulated SVZ ([@bib10]). We injected BrdU three times during the last 24 hr and analyzed the extent of microglial/macrophage proliferation in polyps using IBA1 as a microglia/macrophage marker. Only 2.2% of IBA1^+^ cells (7/324 cells in five animals) were displaying BrdU immunoreactivity, indicating migration of IBA1^+^ cells into the EGF-stimulated, hyperproliferative SVZ, rather than local proliferation.

Angiogenesis in Polyps Is Preceded by Microglia/Macrophage Accumulation {#sec2.3}
-----------------------------------------------------------------------

Using the established criteria for polyps staging, we measured the average cross-sectional area of the polyps at stages I--IV ([Figure 2](#fig2){ref-type="fig"}E). The average area of polyps increased according to stage designation, with stage III polyps showing a larger cross-sectional area compared to stage I, and stage IV polyps having the largest cross-sectional area compared to all other stages ([Figure 2](#fig2){ref-type="fig"}E).

Moreover, from stage I to III the density of IBA1^+^ cells increased substantially, being 3-fold higher in stage III polyps compared to stage I polyps. At stage IV, the density decreased to one-third compared to stage III, a level comparable to stage II ([Figure 2](#fig2){ref-type="fig"}F). In stage III polyps, IBA1^+^ cells were frequently found tightly associated to vessel sprouts. The IBA1^+^ cells aggregated in cage-like structures around the angiogenic vessels, which were covered by strongly NG2 immunoreactive-activated pericytes ([Figure 2](#fig2){ref-type="fig"}G).

Microglia activation is a multistep process based on functional, morphological, and antigenic features ([@bib20]). CD68 is a lipoprotein used as a marker for late-stage microglial activation. IBA1^+^/CD68^+^ cells were found in polyps at all stages ([Figures 2](#fig2){ref-type="fig"}I--2L). No significant differences were found between any of the stages. The average percentage of CD68-expressing IBA1^+^ cells was between 20%--30% in all groups ([Figure 2](#fig2){ref-type="fig"}H).

Unique Morphological and Ultrastructural Features of Polyp-Associated Microglia/Macrophages {#sec2.4}
-------------------------------------------------------------------------------------------

The increasing accumulation of microglia/macrophages in the polyp stages, leading to angiogenesis in stage III, suggests an involvement of microglia/macrophages in the angiogenic process. By acquiring high-density confocal z stacks of IBA1-labeled cells, we were able to distinguish additional morphological features of microglia/macrophages in angiogenic polyps. As previously described, amoeboid microglia/macrophages were frequently found in stage III polyps. Further analysis revealed large cytosolic compartments and tight association of amoeboid microglia/macrophages that occasionally formed clusters and "string of pearl" structures ([Figure 3](#fig3){ref-type="fig"}A). This morphology suggests a common cytosolic syncytium between several microglia/macrophages, similar to what is observed in the development in multinucleated giant cells or cytoplasmic bridges ([@bib15; @bib31; @bib18]).

To study microglia/macrophage ultrastructure in angiogenic and vascularized areas, we utilized transmission electron microscopy. We found cells in the polyp stroma fitting the criteria of amoeboid microglia/macrophages, with an abundance of intracellular vesicles and a rounded cell shape. Moreover, these cells occasionally contained cholesterol crystals and intracellular vesicles ([Figure 3](#fig3){ref-type="fig"}B), suggesting phagocytic activity ([@bib41; @bib21]). The phagocytic phenotype suggests a phagosomal and/or lysosomal nature of the intracellular vesicles. Other cells displayed an ultrastructure that inferred a less-activated state, which lacked cholesterol crystals, had a more ramified morphology, and still harbored intracellular vesicles ([Figure 3](#fig3){ref-type="fig"}C).

Progressive Cell Death in Developing Polyps, Declining after Angiogenesis {#sec2.5}
-------------------------------------------------------------------------

The accumulation and phagocytic activity of microglia/macrophages in the core of the growing polyps could be a consequence of extensive cell death. We used ApopTag labeling to quantify cell death in stage I--IV polyps ([Figure 3](#fig3){ref-type="fig"}D). Stage I polyps rarely contained ApopTag^+^ cells ([Figure 3](#fig3){ref-type="fig"}E). In stage II polyps, ApopTag^+^ cells were occasionally found in the core of the polyps, in areas of IBA1^+^ cell accumulation ([Figure 3](#fig3){ref-type="fig"}F). The density of ApopTag^+^ cells increased drastically in stage III polyps, concurrent with increasing microglia/macrophage accumulation ([Figure 3](#fig3){ref-type="fig"}G). In angiogenic stage IV polyps, prominent cell death was still evident ([Figure 3](#fig3){ref-type="fig"}H), albeit at a lower level, compared to stage III polyps.

Discussion {#sec3}
==========

In the current study we demonstrate how EGF infusion leads to polyp development, microglia/macrophage accumulation, and cell death resulting in focal angiogenesis (summarized in [Figure 4](#fig4){ref-type="fig"}). Angiogenesis is visible after 14 days of EGF infusion; however, a microglia/macrophage response is present already after 7 days of infusion, preceding angiogenesis. The microglia/macrophage accumulation is concurrent with substantial cell death in the polyp core. Moreover, a significant increase in polyp size is observed when comparing stage III angiogenic polyps to stage IV vascularized polyps, indicating a requirement of angiogenesis for excessive polyp growth.

The delayed response of the SVZ vasculature to grow toward and into the polyps, occurring after more than 7 days of EGF infusion, suggests an indirect mechanism, such as hypoxia, rather than a direct angiogenic effect of EGF infusion. In the cerebral cortex, hypoxia-induced angiogenesis is initiated 7 to 14 days after induction of hypoxia ([@bib30]). The accumulation of microglia/macrophages and dying cells in the core of stage III polyps and the subsequent reduction in angiogenic stage IV polyps further strengthens this notion. Whether the microglia/macrophages are attracted by hypoxia-induced signaling or by cell death-related signals remains to be elucidated. However, in the angiogenic stage III polyps, microglia/macrophages adopt an amoeboid morphology, engulf nuclei of dying cells, and display ultrastructural features, suggesting an active role in scavenging dead or dying cells. Microglia and macrophages occasionally express EGFR, and EGF can stimulate microglia migration, acting as a motility factor ([@bib34; @bib35; @bib24; @bib36]). However, EGFR expression and chemotactic effects of EGF on microglia/macrophages in vivo appears to be limited to disease contexts like trauma, neuroinflammation, and atherosclerosis ([@bib24; @bib36]). This could help explain the local, rather than general, microglia/macrophage recruitment after EGF/ TGFα infusion, specifically to hyperproliferative areas with extensive cell death in the SVZ demonstrated here and by others ([@bib10]). One possible mechanism behind the microglia/macrophage recruitment could be through production of cytokines like CCL2/MCP-1, TNFα, or IL-1β by microglial cells resident in the growing polyps in response to local hypoxia, like those previously described after hypoxia in the neonatal brain ([@bib11; @bib12]). Interestingly, amoeboid microglial cells produce MCP-1 under hypoxia in vitro and express the MCP-1 receptor CCR2 in vivo. When MCP-1 was injected intracerebrally amoeboid microglia cells migrated toward the injection site ([@bib12]). Furthermore, the altered morphology of microglia/macrophages and close association to angiogenic vessels we observe, which occur in stage IV polyps, could represent a change from an angiogenesis-promoting to a vessel-stabilizing role of microglia/macrophages. In the retina, transplanted bone marrow-derived cells differentiate into microglia and promote vessel normalization in a HIF1α-dependent manner ([@bib37]).

SVZ expansion after EGF treatment is to a large extent caused by extensive proliferation of dysplastic SOX2/OLIG2-expressing cells ([@bib27]). This dysplastic cell type is highly enriched in the polyps and could be involved in microglia/macrophage accumulation and polyp angiogenesis, via paracrine angiogenic signaling. For instance, neural stem cells are known to produce substantial amounts of vascular endothelial growth factor (VEGF) in vitro ([@bib38]). Although VEGF does not appear to induce further proliferation of neural stem cells in vitro in the presence of growth factors, neural stem cell-derived VEGF could induce angiogenesis through endothelial cell proliferation ([@bib16]). The polyps are not only unique in their composition of cells. They lack an ependymal cell layer and the polyps are freely exposed to molecules present in the cerebrospinal fluid ([@bib27]). This could alter the availability of both chemoattractants and angiogenic growth factors in the polyps.

Adult neural stem cells have been suggested as the cells of origin of certain brain tumors ([@bib44]). Neural stem cells from animals deficient in *p16* (*Ink4a*) and *p19* (*Arf*) that are retrovirally induced to express constitutively active EGFR persistently form glioma-like tumors in vivo ([@bib3]). Moreover, overexpression of wild-type *Egfr* in white matter glial progenitors keeps cells in an immature state, induces extensive migration, and leads to formation of tumor-like white matter hyperplasias ([@bib19]). A small population of stem cell-like cells has been suggested to exist in brain tumors that are treatment resistant and capable of generating secondary tumors ([@bib40]). Much like the supportive niche of neural stem cells, brain tumors appear to modulate the microenvironment to provide conditions promoting stemness ([@bib6]). A study investigating human glioblastoma multiforme tumor progression and brain location demonstrated increased risk of multifocal growth and tumor recurrence in tumors located close to the SVZ ([@bib26]). The present study indicates that the SVZ neural stem cell niche can respond to the extensive hyperproliferation by inducing angiogenesis in hyperproliferative areas, possibly supported by microglia/macrophages. Microglia/macrophages in polyps could play a role similar to tumor-associated macrophages, known to contribute to angiogenic processes in tumors ([@bib33; @bib7]).

Our results suggest that mechanisms formerly attributed to tumor cells, such as angiogenesis, can be induced in the neurogenic niche. This indicates that some differences between stem cells and tumor cells are context dependent rather than cell intrinsic. Furthermore, our results demonstrate the importance of nonneurogenic cell types in the SVZ niche in the progression of the polyps and their acquired angiogenesis. Whether the observed angiogenesis is more closely related to physiological or pathological angiogenesis remains to be elucidated. Nonetheless, the EGF-infusion model could be useful for increasing our understanding of the events that precede proliferation-related angiogenesis in both health and disease.

Experimental Procedures {#sec4}
=======================

Surgery and Tissue Preparation {#sec4.1}
------------------------------

All experiments were approved by the Gothenburg Committee of the Swedish Animal Welfare Agency (application nos. 214-07 and 145-10). Male Wistar rats (Charles River), 7--8 weeks old, were used in the study. Animals were housed in a barrier facility with ad libitum access to food and water with a 12 hr light/dark cycle. All surgeries were performed under ketamine (33 mg/ml Ketalar, Pfizer) and xylazine (6.67 mg/ml Rompun, Bayer Healthcare AG) anesthesia. The animals were divided into groups receiving either vehicle (aCSF) or EGF (360 ng/day). EGF or vehicle was administered for 7 or 14 days using osmotic minipumps (Model 1002; Alzet-Durect) and infusion cannulas (Brain Infusion Kit 2; Alzet-Durect). The surgeries were performed as previously described ([@bib27]). All animals received three intraperitoneal injections of 50 mg/kg of BrdU during the last 24 hr before perfusion. At the end of the EGF infusion period, animals used for immunofluorescence were sedated using an overdose of pentobarbital and transcardially perfused with sterile 0.9% NaCl followed by phosphate-buffered (0.1 M \[pH 7.4\]) 4% paraformaldehyde (PFA). Following perfusion, brains were removed and postfixed in 4% PFA for 24 hr and prepared for cryosectioning by incubation in phosphate-buffered (0.1 M \[pH 7.4\]) 30% sucrose for at least 3 days. All brains were cryosectioned coronally in 40 μm thick serial sections using a sliding microtome (Leica Microsystems) and collected as serial sections (1 in 12 series with 480 μm distance between sections).

Electron Microscopy {#sec4.2}
-------------------

For transmission electron microscopy (TEM), animals were perfused with 0.9% NaCl, followed by 2% PFA and 0.2% glutaraldehyde. The brains were postfixed in 2% PFA and 0.2% glutaraldehyde for 2 hr and stored in 1% PFA at 4°C. The tissue was sectioned at a thickness of 50 μm using a Leica VT1000S vibratome (Leica Microsystems). Tissue was further processed and cut as previously described ([@bib27]). Sections, 60--70 nm thick, were imaged using a LEO912AB transmission electron microscope (Zeiss) equipped with a Megaview III CCD camera (Olympus Soft Imaging Solutions).

Immunohistochemistry {#sec4.3}
--------------------

For fluorescent immunohistochemistry, the sections were washed in Tris-buffered saline (TBS). Sections used for BrdU immunofluorescence were treated with 2M HCl for 30 min at 37°C, followed by neutralization in 0.1 M borate buffer. All sections were blocked for 1 hr in TBS with 3% donkey serum and 0.1% Triton-X at room temperature, prior to primary antibody incubation. The following primary antibodies were used: mouse α-rat endothelial cell antigen-1 (RECA-1, 1:300, Monosan), goat α-IBA1 (1:1,000, Abcam), rabbit α-IBA1 (1:1,000, Wako), mouse α-rat CD68 (1:1,000, Millipore), rat α-BrdU (1:500, Serotech), and rabbit α-NG2 (1:500, Millipore). Primary antibody incubation was performed at 4°C for 24--72 hr, followed by washing in TBS. Secondary antibody incubation was performed at room temperature for 2 hr. The following secondary antibodies were used: donkey (dk) α-rabbit IgG CF555, dk α-goat IgG CF555, dk α-goat IgG CF633, dk α-mouse IgG CF488 (Biotium), dk α-rabbit Alexa 488, dk α-goat Alexa 488, and dk α-rat Alexa 488 (Molecular Probes). TOPRO3 was used as nuclear stain (Molecular Probes). After secondary antibody incubation, the sections were washed in TBS and mounted using ProLong Gold with DAPI (Molecular Probes).

Cell Death {#sec4.4}
----------

For analysis of cell death, ApopTag Fluorescein Direct in situ apoptosis detection kit (Millipore) was used. Sections were mounted on Superfrost Plus microscope slides (Thermo Scientific) and dehydrated in increasing concentrations of ethanol (70--99, 5%), followed by a quick submersion in xylene, rehydration, and wash in TBS. Subsequently, the sections were postfixed in 70% ethanol and acetic acid mixed 2:1 at −20°C for 5 min. To allow proper designation of polyp stage, microglial cells and macrophages were labeled using an Rb α-IBA1 primary antibody (Wako). Following 30 min of blocking, the sections were incubated with the primary antibody for 30 min at 37°C. After washing in TBS sections were incubated with a dk α-rabbit Alexa 555 secondary antibody and TOPRO3 nuclear dye for 30 min at 37°C, followed by washing. Dying cells were labeled in accordance with the manufacturer's instructions.

Confocal Microscopy and Quantification {#sec4.5}
--------------------------------------

Immunofluorescence was visualized using a Leica SP2 (Leica Microsystems) and a Zeiss LSM 710 (Carl Zeiss) inverted confocal microscope. The image stacks were processed in ImageJ (<http://rsbweb.nih.gov/ij/>) and arranged in Adobe Photoshop CS5 and Adobe Illustrator CS5 (Adobe Systems). When studying double labeling, image stacks were acquired at 0.5 μm increments, and orthogonal views were used to determine colocalization and double labeling in single cells. Images used for quantification of polyp size, IBA1^+^ cell density, and IBA1/CD68 coexpression, and ApopTag labeling was quantified in ImageJ using the LOCI plugin.

Statistics {#sec4.6}
----------

All statistical analysis was performed in Prism 6 (Graphpad Software). Means in polyp size comparing 7 and 14 days are presented with standard deviation and compared using a two-tailed Student's t test. For statistical analysis comparing more than two groups, a one-way ANOVA was used, in conjunction with Tukey's post-hoc test and presented as means ± SEM. Differences in means resulting in values of p \< 0.05 were considered statistically significant.
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![EGF Infusion Induces Polyp Formation and Polyp-Associated Angiogenesis\
(A--E) Endothelial cells visualized by RECA-1 (green) and nuclei labeled using TOPRO3 (red) in the vehicle-treated control SVZ (aCSF) (A) and in EGF-induced polyps SVZ (B--D). Polyps formed after 7 days of EGF infusion were present as convex protrusions from the SVZ (B) or as slightly larger spherical structures (C). Following 14 days of EGF infusion polyps were larger and persistently displayed blood vessel recruitment (D) or a complex vascular network in the polyp core (E). Scale bars, 50 μm.](gr1){#fig1}

![IBA1^+^ Cell Accumulation, Distribution, and Activation in EGF-Induced Polyps\
(A) Microglia/macrophages (IBA1) in small polyps are ramified in appearance with numerous long processes (stage I).\
(B) In spherical, slightly larger polyps IBA1^+^ cells adopt a more reactive morphology with a rounded shape and short processes (stage II).\
(C) Polyp with extensive IBA1^+^ cell accumulation and aggregation of amoeboid IBA1^+^ cells in the polyp core (stage III).\
(D) IBA1^+^ cells of vascularized polyps are predominately not amoeboid and frequently line blood vessels (RECA, in red) (stage IV).\
(E) Mean cross-sectional area of polyps stages I--IV (F \[3, 20\] = 58.47, p \< 0.0001).\
(F) Density of IBA1-labeled IBA1^+^ cells in polyps stages I--IV (F \[3, 17\] = 54.90, p \< 0.0001).\
(G) IBA1^+^ cells forming a cage-like structure around angiogenic vessel sprouts. Activated pericytes in angiogenic vessel labeled using NG2.\
(H) Percentage of IBA1^+^ cells coexpressing marker of activation CD68 in polyps stages I--IV (F \[3, 12\] = 0.6653, p = 0.5893).\
(I--L) Representative images of IBA1 and CD68 expression in polyps stages I--IV.\
Scale bars, 25 μm (A--D), 15 μm (G), and 50 μm (I--L). In (E), n(I) = 8, n(II) = 6, n(III) = 5, n(IV) = 5. In (F), n(I) = 5, n(II) = 7, n(III) = 3, n(IV) = 6. In (H), n(I) = 4, n(II) = 3, n(III) = 3, n(IV) = 6. All data are presented as mean ± SEM. ^∗^p \< 0.05; ^∗∗∗^p \< 0.001.](gr2){#fig2}

![Morphological and Ultrastructural Features of Polyp Microglia/Macrophages and Polyp-Associated Cell Death\
(A) IBA1^+^ cells in angiogenic polyps displaying tight cell-cell association and "string of pearl" structure (arrows) (A). yz axis (A′) and yx (A″) projection of confocal image stack acquired in (A), showing IBA1^+^-labeled microglia/macrophage clusters (boxes).\
(B) Transmission electron microscopy micrograph of amoeboid cell with intracellular vesicles (^∗^) and cholesterol crystals (arrows) in polyp.\
(C) Cell with an abundance of intracellular vesicles (^∗^).\
(D) Density of ApopTag-labeled cells in polyps stages I--IV (F \[3, 20\] = 15,31, p \< 0.0001).\
(E--H) Representative images of ApopTag (green) and IBA1 (red) in polyps stages I--IV.\
Scale bars, 20 μm (A), 2 μm (B and C), and 50 μm (E--H). In (D), n(I) = 5, n(II) = 9, n(III) = 6, n(IV) = 4. All data are presented as mean ± SEM. ^∗^p \< 0.05; ^∗∗∗^p \< 0.001.](gr3){#fig3}

![Summary of Microglia/Macrophage Invasion, Cell Death, and Angiogenesis in EGF-Induced Polyps\
During the growth of EGF-induced polyps, cell death increases and microglia/macrophages gradually accumulate in the polyp core and adopt an amoeboid morphology (stages I--III). At stage III of polyp development, cell death and microglia/macrophage accumulation reach their peak, and the first signs of angiogenesis are present. As vascularization increases in stage IV polyps, cell death and microglia/macrophage density declines and polyp size increases substantially. Microglia/macrophages associate closely to newly formed vessels and adopt a more ramified morphology.](gr4){#fig4}
